People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amplyx Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $116.6M | $3.2B | 2015 |
| BlueWhale Bio, Inc. | — | Biotechnology | Series A | $5.0M | $14.2M | 2025 |
| Zephyrus Biosciences, Inc. | — | Biotechnology | Pre-Seed | $300K | $16.6M | 2014 |
Elaine Heron at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Elaine Heron on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Meister | 1 | 12 |
| Edward Mathers | 1 | 12 |
| Ed Mathers | 1 | 11 |
| Michael Grey | 1 | 10 |
| Douglas Crawford | 1 | 8 |
| ANAND MEHRA | 1 | 7 |
| Mitchell Mutz | 1 | 5 |
| Alan Fuhrman | 1 | 5 |
| Paul Grint | 1 | 5 |
| Johan Kordel | 1 | 4 |
| Karen Talmadge | 1 | 3 |
| Santosh Vetticaden | 1 | 2 |
| Chrysa Mineo | 1 | 2 |
| Ciara Kennedy | 1 | 2 |
| Niall ODonnell | 1 | 1 |
| Jack Florio | 1 | 1 |
| Kelly Gardner | 1 | 1 |
| Joshua Molho | 1 | 1 |
| Peter Keller | 1 | 1 |
| Paula Cannon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.